138 related articles for article (PubMed ID: 24662794)
21. Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.
Tombolan L; Poli E; Martini P; Zin A; Millino C; Pacchioni B; Celegato B; Bisogno G; Romualdi C; Rosolen A; Lanfranchi G
BMC Cancer; 2016 Nov; 16(1):886. PubMed ID: 27842508
[TBL] [Abstract][Full Text] [Related]
22. Zebrafish Rhabdomyosarcoma.
Phelps M; Chen E
Adv Exp Med Biol; 2016; 916():371-89. PubMed ID: 27165362
[TBL] [Abstract][Full Text] [Related]
23. Update on molecular findings in rhabdomyosarcoma.
El Demellawy D; McGowan-Jordan J; de Nanassy J; Chernetsova E; Nasr A
Pathology; 2017 Apr; 49(3):238-246. PubMed ID: 28256213
[TBL] [Abstract][Full Text] [Related]
24. Proteomic Profiling of Rhabdomyosarcoma-Derived Exosomes Yield Insights into Their Functional Role in Paracrine Signaling.
Rammal G; Fahs A; Kobeissy F; Mechref Y; Zhao J; Zhu R; Diab-Assaf M; Saab R; Ghayad SE
J Proteome Res; 2019 Oct; 18(10):3567-3579. PubMed ID: 31448612
[TBL] [Abstract][Full Text] [Related]
25. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
[TBL] [Abstract][Full Text] [Related]
26. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
Jankowski K; Kucia M; Wysoczynski M; Reca R; Zhao D; Trzyna E; Trent J; Peiper S; Zembala M; Ratajczak J; Houghton P; Janowska-Wieczorek A; Ratajczak MZ
Cancer Res; 2003 Nov; 63(22):7926-35. PubMed ID: 14633723
[TBL] [Abstract][Full Text] [Related]
27. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
Yu L; Wang J
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
[TBL] [Abstract][Full Text] [Related]
28. Rhabdomyosarcoma: molecular analysis of Igf2, MyoD1 and Myogenin expression.
Krskova L; Augustinakova A; Drahokoupilova E; Sumerauer D; Mudry P; Kodet R
Neoplasma; 2011; 58(5):415-23. PubMed ID: 21744995
[TBL] [Abstract][Full Text] [Related]
29. Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members.
Megiorni F; Cialfi S; McDowell HP; Felsani A; Camero S; Guffanti A; Pizer B; Clerico A; De Grazia A; Pizzuti A; Moles A; Dominici C
BMC Cancer; 2014 Nov; 14():880. PubMed ID: 25427715
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of Kv1.3 and Kv1.5 voltage-dependent K+ channels in human skeletal muscle sarcomas.
Bielanska J; Hernández-Losa J; Moline T; Somoza R; Ramón y Cajal S; Condom E; Ferreres JC; Felipe A
Cancer Invest; 2012 Mar; 30(3):203-8. PubMed ID: 22360360
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical analysis of a muscle ankyrin-repeat protein, Arpp, in paraffin-embedded tumors: evaluation of Arpp as a tumor marker for rhabdomyosarcoma.
Ishiguro N; Motoi T; Osaki M; Araki N; Minamizaki T; Moriyama M; Ito H; Yoshida H
Hum Pathol; 2005 Jun; 36(6):620-5. PubMed ID: 16021567
[TBL] [Abstract][Full Text] [Related]
32. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
[TBL] [Abstract][Full Text] [Related]
33. Dysregulated Myogenesis in Rhabdomyosarcoma.
Yu PY; Guttridge DC
Curr Top Dev Biol; 2018; 126():285-297. PubMed ID: 29305002
[TBL] [Abstract][Full Text] [Related]
34. TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle.
Zhu B; Zhang M; Williams EM; Keller C; Mansoor A; Davie JK
Oncogene; 2016 Aug; 35(32):4212-24. PubMed ID: 26686089
[TBL] [Abstract][Full Text] [Related]
35. The RhoE/ROCK/ARHGAP25 signaling pathway controls cell invasion by inhibition of Rac activity.
Thuault S; Comunale F; Hasna J; Fortier M; Planchon D; Elarouci N; De Reynies A; Bodin S; Blangy A; Gauthier-Rouvière C
Mol Biol Cell; 2016 Sep; 27(17):2653-61. PubMed ID: 27413008
[TBL] [Abstract][Full Text] [Related]
36. Rhabdomyosarcomas: an overview on the experimental animal models.
Zanola A; Rossi S; Faggi F; Monti E; Fanzani A
J Cell Mol Med; 2012 Jul; 16(7):1377-91. PubMed ID: 22225829
[TBL] [Abstract][Full Text] [Related]
37. Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors.
Drummond CJ; Hanna JA; Garcia MR; Devine DJ; Heyrana AJ; Finkelstein D; Rehg JE; Hatley ME
Cancer Cell; 2018 Jan; 33(1):108-124.e5. PubMed ID: 29316425
[TBL] [Abstract][Full Text] [Related]
38. In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells.
Niesen J; Brehm H; Stein C; Berges N; Pardo A; Fischer R; Ten Haaf A; Gattenlöhner S; Tur MK; Barth S
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1049-61. PubMed ID: 25433506
[TBL] [Abstract][Full Text] [Related]
39. Results of a prospective minimal disseminated disease study in human rhabdomyosarcoma using three different molecular markers.
Sartori F; Alaggio R; Zanazzo G; Garaventa A; Di Cataldo A; Carli M; Rosolen A;
Cancer; 2006 Apr; 106(8):1766-75. PubMed ID: 16544315
[TBL] [Abstract][Full Text] [Related]
40. Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases.
Mentzel T; Kuhnen C
Virchows Arch; 2006 Nov; 449(5):554-60. PubMed ID: 17013628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]